Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients
- PMID: 16143707
- DOI: 10.1093/eurheartj/ehi481
Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients
Abstract
Aims: Peripartum cardiomyopathy (PPCM) is a disorder of unknown aetiology with a course and outcome that is largely unpredictable. We evaluated the prognostic role of multiple inflammatory markers in the plasma of a large cohort of African patients with PPCM.
Methods and results: The study of 100 patients with newly diagnosed PPCM was single-centred, prospective, and longitudinal. Clinical assessment, echocardiography, and blood analysis were done at baseline and after 6 months of standard therapy. Inflammatory markers were measured at baseline only. Fifteen patients died. Left ventricular ejection fraction (LVEF) improved from 26.2+/-8.2 to 42.9+/-13.6% at 6 months (P<0.0001). However, normalization of LVEF (>50%) was only observed in 23%. Baseline levels of C-reactive protein correlated positively with baseline LV end-diastolic (rs=0.33, P=0.0026) and end-systolic (rs=0.35, P=0.0012) diameters and inversely with LVEF (rs=-0.27, P=0.015). Patients who died presented with significantly lower mean EF and higher Fas/Apo-1 plasma values (P<0.05). Fas/Apo-1 and New York Heart Association functional class (NYHA FC) predicted mortality at baseline.
Conclusion: Plasma markers of inflammation were significantly elevated and correlated with increased LV dimensions and lower LVEF at presentation. Baseline Fas/Apo-1 and higher NYHA FC were the only predictors of mortality. Normalization of LVEF was only observed in 23% of this African cohort.
Similar articles
-
Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.J Am Coll Cardiol. 2007 Nov 6;50(19):1896-904. doi: 10.1016/j.jacc.2007.09.004. Epub 2007 Oct 22. J Am Coll Cardiol. 2007. PMID: 17980258
-
Changes in B-type natriuretic peptides after surgical ventricular restoration.Eur J Cardiothorac Surg. 2007 May;31(5):922-8. doi: 10.1016/j.ejcts.2007.01.038. Epub 2007 Feb 23. Eur J Cardiothorac Surg. 2007. PMID: 17321144
-
Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.Cardiol J. 2009;16(1):43-9. Cardiol J. 2009. PMID: 19130415
-
[Peripartum cardiomyopathy-the (un)known obstetricalcardiologic emergency situation].Z Kardiol. 2003 Oct;92(10):811-6. doi: 10.1007/s00392-003-0981-9. Z Kardiol. 2003. PMID: 14579044 Review. German.
-
Peripartum cardiomyopathy: an ominous complication of pregnancy.Am J Crit Care. 2000 Sep;9(5):362-6. Am J Crit Care. 2000. PMID: 10976361 Review.
Cited by
-
Peripartum cardiomyopathy: a review.Tex Heart Inst J. 2012;39(1):8-16. Tex Heart Inst J. 2012. PMID: 22412221 Free PMC article. Review.
-
Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy.Basic Res Cardiol. 2013 Jul;108(4):366. doi: 10.1007/s00395-013-0366-9. Epub 2013 Jun 28. Basic Res Cardiol. 2013. PMID: 23812247 Free PMC article.
-
Epidemiology and natural history of recovery of left ventricular function in recent onset dilated cardiomyopathies.Curr Heart Fail Rep. 2013 Dec;10(4):321-30. doi: 10.1007/s11897-013-0157-5. Curr Heart Fail Rep. 2013. PMID: 24014141 Free PMC article. Review.
-
Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry.Eur Heart J. 2020 Oct 14;41(39):3787-3797. doi: 10.1093/eurheartj/ehaa455. Eur Heart J. 2020. PMID: 32840318 Free PMC article.
-
Race, hypertensive disorders of pregnancy and outcomes in peripartum cardiomyopathy.Am Heart J. 2024 Oct;276:60-69. doi: 10.1016/j.ahj.2024.07.002. Epub 2024 Jul 10. Am Heart J. 2024. PMID: 38996860
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous